Literature DB >> 31149297

ASSOCIATION OF THE HUMAN PPARγ2 PRO12ALA POLYMORPHISM WITH OBESITY IN A POPULATION FROM TURKEY.

M A Sözen1, M U Özcan2, M Çıldır2, I H Doğru2, A G Aygök2, K Ü Balkan2.   

Abstract

BACKGROUND: There have been a number of reports on the relationship between the PPARγ2 Pro12Ala genotype and the development of obesity.
OBJECTIVE: A case-control survey was designed to investigate the potential association between a Pro12Ala polymorphism in the PPARγ2 gene and obesity and/or obesity-related phenotypes in a population from Turkey.
MATERIALS AND METHODS: The polymerase chain reaction and restriction enzyme digestion were used to genotype the Pro12Ala polymorphism of the PPARγ2 gene in 149 unrelated obese and 105 non-obese control subjects from Turkey. The data were analyzed statistically.
RESULTS: We found that the overall minor allele frequency was 0.12 in cases and 0.095 in controls. In terms of genotype distribution and allele frequencies among the cases versus controls in the population studied, only the gender-stratified analysis revealed a significantly higher frequency of Pro/Ala genotype within males. The polymorphism was associated with significantly higher weight, height, waist circumference, central adiposity (waist-to-hip ratio, WHR), lean body weight as well as dry body weight, but not overall adiposity (total body fat percentage, TBF) in cases carrying Ala allele (Pro/Ala or Ala/Ala). However, in the subjects carrying Ala allele of the control group, WHR values were found significantly lower.
CONCLUSION: Our results showed that the Pro12Ala polymorphism in the PPARγ2 gene is associated with obesity in the studied adult population from Turkey. These data suggest that the Pro12Ala polymorphism in PPARγ2 may be a potential genetic risk factor for central obesity.

Entities:  

Keywords:  PPARγ2 gene; central obesity; obesity; polymorphism; waist-to-hip ratio

Year:  2018        PMID: 31149297      PMCID: PMC6516403          DOI: 10.4183/aeb.2018.459

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  41 in total

1.  Impact of the Peroxisome Proliferator Activated Receptor gamma2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus.

Authors:  A Meirhaeghe; L Fajas; N Helbecque; D Cottel; J Auwerx; S S Deeb; P Amouyel
Journal:  Int J Obes Relat Metab Disord       Date:  2000-02

2.  A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.

Authors:  M M Swarbrick; C M Chapman; B M McQuillan; J Hung; P L Thompson; J P Beilby
Journal:  Eur J Endocrinol       Date:  2001-03       Impact factor: 6.664

3.  Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.

Authors:  I Barroso; M Gurnell; V E Crowley; M Agostini; J W Schwabe; M A Soos; G L Maslen; T D Williams; H Lewis; A J Schafer; V K Chatterjee; S O'Rahilly
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

4.  The Pro12Ala variant of peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) is associated with measures of obesity in Mexican Americans.

Authors:  S A Cole; B D Mitchell; W C Hsueh; P Pineda; B A Beamer; A R Shuldiner; A G Comuzzie; J Blangero; J E Hixson
Journal:  Int J Obes Relat Metab Disord       Date:  2000-04

5.  Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men.

Authors:  J Ek; S A Urhammer; T I Sørensen; T Andersen; J Auwerx; O Pedersen
Journal:  Diabetologia       Date:  1999-07       Impact factor: 10.122

6.  Significance of Pro12Ala mutation in peroxisome proliferator-activated receptor-gamma2 in Korean diabetic and obese subjects.

Authors:  E Y Oh; K M Min; J H Chung; Y K Min; M S Lee; K W Kim; M K Lee
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

7.  Peroxisome proliferator-activated receptor gamma 2 Pro12Ala gene variant is strongly associated with larger body mass in the Taiwanese.

Authors:  H H Lei; M H Chen; W S Yang; M C Chiu; M C Chen; T Y Tai; L M Chuang
Journal:  Metabolism       Date:  2000-10       Impact factor: 8.694

8.  [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].

Authors:  Mao Fu; Hua Chen; Xiujun Li; Jie Li; Bin Wu; Lihong Cheng; Mengyin Cai; Zuzhi Fu
Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi       Date:  2002-06

9.  Obesity in the new millennium.

Authors:  J M Friedman
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

10.  The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth.

Authors:  Johan G Eriksson; Virpi Lindi; Matti Uusitupa; Tom J Forsén; Markku Laakso; Clive Osmond; David J P Barker
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

View more
  1 in total

1.  Pro12Ala PPAR-γ2 and +294T/C PPAR-δ Polymorphisms and Association with Metabolic Traits in Teenagers from Northern Mexico.

Authors:  Martín A Carrillo-Venzor; Nancy R Erives-Anchondo; Janette G Moreno-González; Verónica Moreno-Brito; Angel Licón-Trillo; Everardo González-Rodríguez; Pilar Del Carmen Hernández-Rodríguez; Sandra A Reza-López; Verónica Loera-Castañeda; Irene Leal-Berumen
Journal:  Genes (Basel)       Date:  2020-07-10       Impact factor: 4.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.